Submitted:
03 September 2025
Posted:
04 September 2025
You are already at the latest version
Abstract
Introduction: The objective of this research was to determine the occurrence of antimicrobial resistant E. coli from barn swallow droppings. There is evidence suggesting that wild birds can spread resistant bacteria through migration and that resistant bacteria can be transmitted from birds to humans and vice versa. Development of antibiotic resistance among pathogenic bacteria in wild living birds remains a major alarming public health concern. Spreading of antimicrobial resistant organisms may result into exposing antibiotic resistant genes to humans making treatment difficult and expensive. This study was focused on analysis of fecal samples from barn swallow (Hirundo rustica) droppings in Bushenyi Town and Sheema town, Uganda, for the presence of antibiotic resistant E. coli strains. Materials and methods: Bird fecal samples were cultured to isolate E. coli. The isolates were subjected to antibiotic sensitivity testing using standard procedures. The results were interpreted using Clinical and Laboratory Standards Institute guidelines. Results: Out of 58 samples tested, 21 samples were positive for E. coli which is equivalent to 36.2%. All isolates were found resistant to Augmentin, amoxicillin and Ampiclox. Resistance to other antibiotics starting from the most resistant bacteria were as follows; erythromycin (85.7%), ceftazidime (71.4%) and chloramphenicol (61.9%). It was noted that E. coli is still susceptible to gentamicin (100%), ofloxacine (90.5%) and imipenem (76.2%) in Sheema and Bushenyi. Resistance to ciprofloxacin (57.1%) and Nalidixic acid (23.9%) is still intermediate; All isolates were resistant to one or more of the tested antibiotics. 77.8% and 83.3% of isolates from Sheema and Bushenyi respectively were resistant to at least three or more classes of antibiotics tested (Multi-drug resistance). Conclusion: Detection of antibiotic resistant E. coli in Barn swallows not only indicates a potential risk of transferring resistance to humans but also shows the status of antibiotic resistance within the ecosystem in which the Barn swallows interact with humans. This study has shown that isolated E. coli from bird droppings are resistant to most antibiotics that were used. This can potentially pose a risk of spread of resistance from wild birds to humans in these areas. Much attention is needed to reduce the risks of transmission of resistance from birds and help us to better understand the dissemination of antibiotic resistance in the environment.
Keywords:
Introduction
Materials and Methods
Bird Fecal Sample Collection
Culturing and Isolation of E. coli Strains
Susceptibility Testing
Results
Isolation and Identification of Escherichia coli
Antimicrobial Susceptibility of the Escherichia coli Isolates
Overall Resistance Patterns of the E. coli Isolates from Barn Swallow Droppings from Both Sheema and Bushenyi Towns
Discussion
Conclusions and Recommendation
References
- Spellberg, B.; Gilbert, D.N. The Future of Antibiotics and Resistance: A Tribute to a Career of Leadership by John Bartlett. Clinical Infectious Diseases 2014, 59 (Suppl. 2), S71–S75. [Google Scholar] [CrossRef]
- Grobbel, M.; Lübke-Becker, A.; Alesík, E.; Schwarz, S.; Wallmann, J.; Werckenthin, C.; Wieler, L.H. Antimicrobial susceptibility of Escherichia coli from swine, horses, dogs and cats as determined in the BfT-GermVet monitoring program 2004-2006. Berliner Und Munchener Tierarztliche Wochenschrift 2006, 120, 391–401. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17939454.
- Sarmah, A.K.; Meyer, M.T.; Boxall, A.B.A. A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment. Chemosphere 2006, 65, 725–759. [Google Scholar] [CrossRef] [PubMed]
- Guenther, S.; Grobbel, M.; Lübke-Becker, A.; Goedecke, A.; Friedrich, N.D.; Wieler, L.H.; Ewers, C. Antimicrobial resistance profiles of Escherichia coli from common European wild bird species. Veterinary Microbiology 2010, 144, 219–225. [Google Scholar] [CrossRef]
- Caprioli, A.; Donelli, G.; Falbo, V.; Passi, C.; Pagano, A.; Mantovani, A. Antimicrobial Resistance and Production of Toxins in Escherichia coli Strains from Wild Ruminants and the Alpine Marmot. Journal of Wildlife Diseases 1991, 27, 324–327. [Google Scholar] [CrossRef]
- Baquero, F.; Martinez, J.L.; Canton, R. Antibiotics and antibiotic resistance in water environments. Curr Opin Biotechnol 2008, 19, 260–265. [Google Scholar] [CrossRef]
- Cole, D.; Drum, D.J.V.; Stallknecht, D.E.; White, D.G.; Lee, M.D.; Ayers, S.; … Maurer, J.J. Free-living Canada Geese and antimicrobial resistance. Emerging Infectious Diseases 2005, 11, 935–938. [Google Scholar] [CrossRef] [PubMed]
- Allen, H.; Donato, J. Call of the wild: antibiotic resistance genes in natural environments. Nature Reviews 2010, 8, 251–259. [Google Scholar] [CrossRef] [PubMed]
- Dolejska, M.; Cizek, A.; Literak, I. High prevalence of antimicrobial-resistant genes and integrons in Escherichia coli isolates from Black-headed Gulls in the Czech Republic. Journal of Applied Microbiology 2007, 103, 11–19. [Google Scholar] [CrossRef]
- Veldman, K.; van Tulden, P.; Kant, A.; Testerink, J.; Mevius, D. Characteristics of cefotaxime-resistant Escherichia coli from wild birds in The Netherlands. Applied and Environmental Microbiology 2013, 79, 7556–7561. [Google Scholar] [CrossRef]
- Bonnedahl, J.; Drobni, P.; Johansson, A.; Olsen, B.; Drobni, M. Characterization, and comparison, of human clinical and black-headed gull (Larus ridi-bundus) extended-spectrum beta-lactamase-producing bacterial isolates from Kalmar, on the south-east coast of Sweden. J. Antimicrob. Chemother 2010, 65, 1939–1944. [Google Scholar] [CrossRef]
- Simoes, R.; Poirel, L.; Costa, P.D.; Nordmann. Sea gulls and beaches as reservoirs for multidrug resistant Escherichia coli. Emerg. Infect. Dis. 2010, 16, 110–112. [Google Scholar] [CrossRef]
- Allen, H.K.; Donato, J.; Wang, H.H.; Cloud-Hansen, K.A.; Davies, J.; Handelsman, J. Call of the wild: antibiotic resistance genes in natural environments. Nat Rev Microbiol 2010, 8, 251–9. [Google Scholar] [CrossRef]
- Shobrak, M.Y.; Abo-Amer, A.E. Role of wild birds as carriers of multi-drug resistant Escherichia coli and Escherichia vulneris. Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology] 2014, 45, 1199–209. [Google Scholar] [CrossRef] [PubMed]
- Levine, M.M. Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent. The Journal of Infectious Diseases 1987, 155, 377–89. [Google Scholar] [CrossRef] [PubMed]
- Okullu, T.; Onchweri, A.N.; Miruka, C.O.; Eilu, E.; Abimana, J.B.; Nyabayo, M.J. Antibiotic Resistant Escherichia coli Isolates from Barn Swallow Droppings in Ishaka Town, Uganda. Journal of Applied & Environmental Microbiology 2016, 4, 34–38. [Google Scholar] [CrossRef]
- Traub, W.H.; Raymond, E.A.; Linehan, J. Identification of Enterobacteriaceae in the Clinical Microbiology Laboratory. 1970, 20, 303–308. [Google Scholar] [CrossRef]
- Kiehlbauch, J.A.; Hannett, G.E.; Salfinger, M.; Archinal, W.; Monserrat, C.; Carlyn, C. Use of the National Committee for Clinical Laboratory Standards Guidelines for Disk Diffusion Susceptibility Testing in New York State Laboratories. J Clin Microbiol 2000, 38, 3341–3348. [Google Scholar] [CrossRef]
- Stiles, M.; Ng, L.-K. Biochemical characteristics and identification of enterobacteriaceae from baked meats. Applied and Environmental Microbiology 1981, 41, 639–645. [Google Scholar] [CrossRef]
- U.S. Environmental Protection Agency. (2010). Standard Analytical Protocol for Escherichia coli O157 : H7 in Water, (September), 1–52.
- Caroline, K.N. Factors Associated with SelfMedication with Antibiotics in Ishaka Division, Bushenyi District. Eurasian Experiment Journal of Scientific And Applied Research 2024, 5, 123–133. [Google Scholar]
- Raida, S.; Kaneene, J.B.; Johnson, Y.; Miller, R.A. Patterns of antimicrobial resistance observed in Escherichia coli isolates obtained from domestic and wild animal fecal samples, Laviein septage and surface water. Appl. Environ. Microbiol. 2005, 7, 1394–1404. [Google Scholar] [CrossRef]
- Nalwoga, J.; Tirwomwe, M.; Onchweri, A.N.; Maniga, J.N.; Nyaribo, C.M.; Miruka, C.O. Drug resistant Staphylococcus aureus in clinical samples at Kampala International University-teaching hospital, Bushenyi District, Uganda. American Journal of Biomedical Research 2016, 4, 94–98. [Google Scholar]
- Ahmed, N.A.; Gulhan, T. Determination of antibiotic resistance patterns and genotypes of Escherichia coli isolated from wild birds. Microbiome 2024, 12, 2024. [Google Scholar] [CrossRef] [PubMed]
| SHEEMA | BUSHENYI | TOTAL | |
| NO. OF SAMPLES TESTED | 25 | 33 | 58 |
| NO. OF SAMPLES POSITIVE FOR Escherichia coli. | 9 | 12 | 21 |
| %POSITIVE FOR Escherichia coli | 36 | 36.36 | 36.21 |
| % RESISTANT | % INTERMEDIATE | %SUSCEPTIBLE | ||||
| ANTIBIOTICS | SHEEMA | BUSHENYI | SHEEMA | BUSHENYI | SHEEMA | BUSHENYI |
| NALIDIXIC ACID (30μg) | 44.44 | 33.33 | 25 | 22.22 | 33.33 | 41.67 |
| CEFTAZIDIME (30μg) | 88.88 | 58.33 | 16.67 | 11.11 | 0 | 25 |
| ERYTHROMYCIN (30μg) | 77.78 | 91.67 | 8.33 | 22.22 | 0 | 0 |
| IMIPENEM (10μg) | 44.44 | 8.33 | 0 | 0 | 0 | 91.67 |
| GENTAMICIN (30μg) | 0 | 0 | 0 | 0 | 100 | 100 |
| OFLOXACIN (10μg) | 0 | 0 | 8.33 | 11.11 | 88.87 | 91.67 |
| AMPICLOX (30μg) | 100 | 100 | 0 | 0 | 0 | 0 |
| STREPTOMYCIN (10μg) | 55.56 | 41.67 | 8.33 | 22.22 | 22.22 | 50 |
| CIPLOFLOXACIN (30μg) | 44.44 | 41.67 | 58.33 | 55.56 | 0 | 0 |
| CHLORAMPHENICOL (30μg) | 66.67 | 58.33 | 0 | 0 | 33.33 | 41.67 |
| AMOXYCILLIN (10μg) | 100 | 100 | 0 | 0 | 0 | 0 |
| AUGUMENTIN (30μg) | 100 | 100 | 0 | 0 | 0 | 0 |
| ANTIBIOTICS DISCS USED | SAMPLES TESTED | % RESISTANT | % INTERMEDIATE | % SUSCEPTIBLE |
| NALIDIXIC ACID (30μg) | 21 | 38.10 | 23.81 | 38.10 |
| CEFTAZIDIME (30μg) | 21 | 71.43 | 14.29 | 14.29 |
| ERYTHROMYCIN (30μg) | 21 | 85.71 | 14.29 | 0 |
| IMIPENEM (10μg) | 21 | 23.81 | 0 | 76.19 |
| GENTAMICIN (30μg) | 21 | 0 | 0 | 100 |
| OFLOXACIN (10μg) | 21 | 0 | 9.524 | 90.48 |
| AMPICLOX (30μg) | 21 | 100 | 0 | 0 |
| STREPTOMYCIN (10μg) | 21 | 47.62 | 14.29 | 38.10 |
| CIPLOFLOXACIN (30μg) | 21 | 42.86 | 57.14 | 0 |
| CHLORAMPHENICOL (30μg) | 21 | 61.90 | 0 | 38.10 |
| AMOXYCILLIN (10μg) | 21 | 100 | 0 | 0 |
| AUGUMENTIN (30μg) | 21 | 100 | 0 | 0 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
